Sabitlenmiş Tweet
Max
3.4K posts
NEW: Rep. Eric Swalwell, who previously said we should “believe survivors,” says we shouldn’t believe the woman who accused him of s*xual assault.
“These allegations of s*xual assault are flat false. They are absolutely false.”
“They did not happen. They have never happened. And I will fight them with everything that I have.”
English
This is incredible.
Nicolas Hulscher, MPH@NicHulscher
🚨BREAKING: Largest Real-World Study of Ivermectin + Mebendazole in Cancer Patients Shows 84.4% Clinical Benefit — Nearly HALF Report Cancer Disappearance or Tumor Regression After just 6 months, 48.4% of cancer patients taking ivermectin and mebendazole reported NO EVIDENCE OF DISEASE (32.8%) or tumor regression (15.6%), while 36.1% reported disease stabilization⬇️ We have completed the largest real-world human analysis to date evaluating ivermectin and mebendazole in cancer patients—and the results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology. The groundbreaking analysis was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel (Dr. Harvey Risch)—uniting real-world clinical data, frontline medical experience, and high-level epidemiologic expertise to deliver urgently needed insights in oncology. This was a real-world prospective clinical program evaluation of 197 cancer patients, with 122 completing a follow-up survey at about six months (61.9% response rate). Cancer patients were prescribed compounded ivermectin–mebendazole, with each capsule containing 25 mg ivermectin and 250 mg mebendazole—most commonly taken at 1–2 capsules per day. The cohort represented a clinically relevant population, including a wide variety cancer types, with 37.1% of patients reporting actively progressing disease at baseline and many having already undergone chemotherapy, radiation, and surgery. At six months, 84.4% of cancer patients reported clinical benefit (Clinical Benefit Ratio: 84.4% [95% CI: 77.0–89.8%]): ✅ 32.8% reported no evidence of disease (95% CI: 25.1–41.5%) ✅ 15.6% reported tumor regression (95% CI: 10.2–23.0%) ✅ 36.1% reported stable disease (95% CI: 28.1–44.9%) Treatment adherence was high, with 86.9% completing the full protocol and 66.4% remaining on therapy at six months. The regimen was well tolerated, with 25.4% reporting side effects, primarily mild and gastrointestinal, and over 93% continuing treatment despite these events. Patients were treated in real-world conditions alongside concurrent therapies, including chemotherapy (27.9%), radiation (21.3%), surgery (19.7%), supplements (49.2%), and dietary modification (37.7%), supporting use as an adjunctive approach. Together, these findings represent a large, internally consistent real-world clinical signal that supports URGENT further investigation of ivermectin and mebendazole as low-toxicity, adjunctive cancer therapies. Given the strength of the signal observed here, advancing this line of investigation is no longer optional—it is necessary. This is NOT the end. We will continue advancing this work with larger datasets to further define and validate the role of anti-parasitics in cancer outcomes. The manuscript is now available as a preprint on the Zenodo research repository, operated by the European Organization for Nuclear Research, while undergoing peer review at leading oncology journals: “Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort.” @twc_health @McCulloughFund @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson
English
Grant Cardone: "The roofer, the HVAC guy, the plumber, and the electrician are going to k*ll AI. They’re going to overperform. The plumber tomorrow is going to make more money than the doctor tomorrow if they know how to hustle."
English
Simple poll. Please be honest! As of today, how much do you still trust this man?
A. 100 % B. 75%
C. 50% D. 25%
E. 0%
English
Max retweetledi
The Google Quantum AI paper (out today) models a *future* cryptographically relevant quantum computer—not today.
Current machines (e.g. Google's Willow: 105 qubits) can't touch it. Their estimate: <500k physical qubits could derive a BTC private key from an exposed public key in ~9 min for an "on-spend" attack, faster than prior projections.
It's a heads-up to migrate to post-quantum crypto in the next 5-10 years. No immediate threat.
English
BREAKING: Google research reveals quantum computers may be able to crack Bitcoin's private keys in just 9 minutes.
English
@patriot_savvy Do these cave people not have a flashlight on their phone
English
Missile Strikes Jihadist Base in Eastern Tehran.
3…
2…
1…
💣 💥🔥💨
English
🚨🚨🚨🚨🚨عااااجل
انشقاق العميد سيد محمد سيد خراساني أحد قيادة القوات الجوية الإيرانية، عن النظام الإيراني
العربية
So many are saying the bear market has officially begun.
No. The bear market is almost over.
And I really think crypto is going to shock everyone this cycle.
I bet my entire life, 10yrs worth of research & entire net worth on this moment.
I’m warning you that life changing wealth is about to come.
The masses do not see this.
When I look at the business cycle… What the US dollar is doing…what Trump is doing…the stimulus that’s coming after years of prolonged draining…What metals are doing. The new FED chair…
Institutional interest in crypto. Retail distributing to big money. The Clarity Act, etc..
Understand that, and you beat 95% of investors.
You all deserve what’s about to happen.
If you still haven’t followed me, you’ll regret it.
English
JUST IN: 🇮🇱 Israeli Prime Minister Netanyahu says "Jesus Christ has no advantage over Genghis Khan."
"If you are strong enough, ruthless enough, and powerful enough, evil will overcome good."
English
